Breakthroughs Blog

Breakthroughs brings you stories of bright ideas and bold innovations in global health.

The Latest
Ansley Kahn
Research Roundup: Chikungunya vaccine trial, Ebola vaccine technology, and Zika biomarkers could lead to prenatal diagnostic

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Recent

Budget update: Congress passes budget package for FY2013, while House and Senate introduce starkly different FY2014 budget proposals

Earlier this week, both the House and Senate passed a budget package to fund the government through the remainder of fiscal year (FY) 2013, thereby averting a government shutdown when current funding expires on March 27.

GHTC
Read More
PATH/Aaron Joel Santos
Film series highlights need for new TB vaccines worldwide

Aeras is excited to share the trailer for a series of short films exposing the underreported global epidemic of TB and the movement for innovation to improve our tools to fight it.

Aeras
Read More
PATH
GHTC members urge Congress to protect global health research funding

Earlier this week, the GHTC and other global health and international development advocates called on the House Appropriations State and Foreign Operations subcommittee to fully fund key programs in the foreign affairs budget.

GHTC
Read More
Panel stresses partnerships and long-term support for successful global health research

“I can’t think of a reason why academic scientists should not engage in global health research,” Dr. Dennis Kyle, distinguished university health professor at the University of South Florida, said last week at the Consortium of Universities for Global Health (CUGH) annual conference.

GHTC
Read More
PATH/Aaron Joel Santos
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Eric Becker
Where the rubber hits the road: Evidence informing impact for global health

In this guest post, E. Callie Raulfs-Wang –research advisor for the US Agency for International Development’s (USAID) Center for Accelerating Innovation and Impact—writes about the relationship between research and evidence when developing and delivering new global health products.

Read More
Microbicides, vaccines, and TB diagnostics Oh my! What’s new in HIV/AIDS research?

In this guest post, Molly Schmalzbach—public affairs analyst in the Office of HIV/AIDS at the US Agency for International Development (USAID)—discusses the agency’s support for research to develop new HIV/AIDS and tuberculosis (TB) products.

Read More
PATH/Evelyn Hockstein
Global health research and development: Advancing women’s right to health

On this day honoring the political, social, and economic contributions women have made worldwide, nearly 2,000 women will die of AIDS and 790 will perish in pregnancy or childbirth. If we wish to truly advance the health and rights of women globally, we must give them the tools they need to protect their own health.

Read More
New details emerging about sequestration that indicate an uncertain future for global health R&D

Although we’re several days into sequestration, details about the full impact of funding cuts are still hazy. On Friday, the Office of Management and Budget (OMB) released a report to Congress, which details funding cuts required to offset $85 billion in the fiscal year (FY) 2013 budget.

GHTC
Read More
Investing in the future: GHTC congressional briefing highlights compelling benefits of global health research

“I’d be careful not to break something that would be hard to put back together,” Alan Magill—director of Malaria at the Bill & Melinda Gates Foundation—said this week at the GHTC’s annual congressional briefing.

GHTC
Read More
Architect of the Capitol
GHTC 2013 report: Clear steps for policymakers to renew the US legacy in global health R&D

We have long known that Washington is operating under a remarkably unorthodox budgetary process.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
A chorus of voices across the government calls for a solution to sequestration

During last week’s State of the Union address, President Obama called on policymakers to find a solution to the federal budget debate before sequestration—or widespread and indiscriminate cuts to all federal programs—takes place next month.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Aaron Joel Santos
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Obama begins second term with new faces, changing leadership in key global health positions

President Obama officially began his second term in office this week, and will have a host of new faces to work with in Congress and his own administration.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Halting the fiscal cliff: How will the latest budget negotiations impact global health and development?

Going into December 2012, Congress had neither completed its work on the federal budget for fiscal year (FY) 2013 nor decided how to avoid sequestration—widespread and indiscriminate cuts to all federal programs.

GHTC
Read More
PATH/Patrick McKern
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH
FDA approval of new TB drug benefits patients and highlights the agency’s lifesaving programs

The New Year has brought some much-needed good news in the fight against tuberculosis (TB). The US Food and Drug Administration (FDA) recently announced that it has approved a new treatment for multidrug-resistant TB that can be used as an alternative when other drugs fail.

GHTC
Read More